Closing prices for 09 October 2026
Next earnings report: 04 November 2026 · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
Viemed Healthcare, Inc. trades on Nasdaq under the ticker VMD. The company belongs to the Health care sector. The trading history on this page starts on 09 August 2019.
Over the past 52 weeks VMD has traded between 6.05 $ and 12.61 $. As of 09 October 2026 the price stood 52.90 % of the way from the 52-week low to the high.
Over one year VMD shares rose 38.57 %; over six months they rose 0.11 %. Volatility over 90 days is 39.89 %. Dividends are not included: this is price change only, as of 09 October 2026.
VMD trades at a price-to-earnings ratio of 24.7, below the sector median of 24.8. Price to sales is 1.3, below the sector median of 3.9. Price to book is 2.5, above the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 9.38 | 9.54 | 9.38 | 9.52 | 152,489 |
| 08 October 2026 | 9.39 | 9.60 | 9.26 | 9.41 | 268,600 |
| 07 October 2026 | 9.32 | 9.53 | 9.32 | 9.37 | 366,600 |
| 06 October 2026 | 9.29 | 9.40 |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Address:625 E. KALISTE SALOOM RD., LAFAYETTE, LA, 70508, US
Viemed Healthcare, Inc. reported revenue of 287M $ and net income of 15M $ over the last four quarters. Net margin is 5.17 %. Revenue changed by +23.10 % year over year. Earnings per share are 0.37 $. Market capitalisation is 366M $.
VMD has a return on equity of 10.29 %, above the sector median of −41.68 %. Return on assets is 7.50 %, above the sector median of −32.11 %. Operating margin is 8.17 %, above the sector median of −26.84 %.
| 19M |
| NIVFNewGenIvf Group Limited | 0.0721 | −31.98 % | 8M |
| MGRXMangoceuticals, Inc. | 0.4220 | −2.31 % | 249,358 |
| BRTXBioRestorative Therapies, Inc. | 1.86 | −1.59 % | 100,407 |
| CCELCryo-Cell International, Inc. | 4.36 | +4.56 % | 56,385 |
| 9.20 |
| 9.33 |
| 260,500 |
| 05 October 2026 | 9.15 | 9.30 | 9.09 | 9.24 | 217,800 |
| 02 October 2026 | 9.17 | 9.17 | 8.91 | 9.13 | 387,700 |
| 01 October 2026 | 9.08 | 9.20 | 9.03 | 9.08 | 265,000 |
| 30 September 2026 | 9.19 | 9.24 | 8.95 | 9.10 | 253,900 |
| 29 September 2026 | 9.01 | 9.24 | 8.96 | 9.23 | 230,800 |
| 28 September 2026 | 8.92 | 9.12 | 8.83 | 9.11 | 336,500 |
| 25 September 2026 | 8.81 | 8.93 | 8.71 | 8.91 | 199,800 |
| 24 September 2026 | 8.80 | 8.86 | 8.66 | 8.82 | 255,600 |
| 23 September 2026 | 8.95 | 8.97 | 8.78 | 8.80 | 213,400 |
| 22 September 2026 | 8.85 | 9.01 | 8.83 | 8.96 | 241,600 |
| 21 September 2026 | 8.90 | 8.97 | 8.69 | 8.85 | 265,000 |
| 18 September 2026 | 8.97 | 9.06 | 8.86 | 8.91 | 414,600 |
| 17 September 2026 | 8.94 | 9.02 | 8.88 | 8.95 | 317,400 |
| 16 September 2026 | 8.78 | 8.96 | 8.75 | 8.94 | 345,000 |
| 15 September 2026 | 8.82 | 8.82 | 8.70 | 8.75 | 178,400 |
| 14 September 2026 | 8.83 | 8.98 | 8.76 | 8.84 | 226,400 |